Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-02-08

FDA Approved: FLURAZEPAM HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)

View source ↗

Summary

The FDA approved a supplemental application for Flurazepam Hydrochloride filed by Chartwell RX, LLC. This action authorizes a modification to the drug's existin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Flurazepam hydrochloride (Flurazepam hydrochloride)

Snippet

SUPPL AP for FLURAZEPAM HYDROCHLORIDE (FLURAZEPAM HYDROCHLORIDE)